The prescription of allopurinol in a tertiary care centre: appropriate indications and dose adjustment
- PMID: 22798723
- PMCID: PMC3394594
- DOI: 10.4137/CMAMD.S9803
The prescription of allopurinol in a tertiary care centre: appropriate indications and dose adjustment
Abstract
Objective: To determine the appropriateness (both indications and adequate dosage regimen via creatinine clearance estimation) of allopurinol by physicians of different specialties in a tertiary care centre.
Patients and methods: In this cross sectional study computerized clinical records of 156 adult patients who were prescribed allopurinol from 12th November to 11th December, 2011 were retrieved from Al Hada Hospital Taif Saudi Arabia. Main outcome variables were approprsiate indications of allopurinol, prescribing physician's specialty, and dosage of allopurinol. The prescribed dosages were categorized into correct and incorrect dose adjustments based on creatinine clearance estimation. The SPSS version 16 was utilized for data analyses.
Results: The mean (±SD) age was 58.15 (±14.99) years. There were 105 (67.3%) males and 51 (32.7%) females with male to female ratio being 2:1. Allopurinol was frequently prescribed by nephrologists and family physicians in this study. Out of 156 patients, 46 (29.5%) patients received allopurinol with appropriate indications. Eighty-five (54.5%) patients were received allopurinol without dose adjustment based on their creatinine clearance estimation; among them, 21 (13.5%) received allopurinol with appropriate indications.
Conclusion: The inappropriate use of allopurinol (both the indication and prescribed dosage) is still a major problem in a large tertiary care centre. Furthermore, the specialty of physicians is also a contributory factor in this inappropriateness.
Keywords: allopurinol; drug prescription; gout; hyperuricemia; indication.
Similar articles
-
Allopurinol prescription patterns among patients in a Saudi tertiary care centre.J Taibah Univ Med Sci. 2020 Apr 27;15(3):185-189. doi: 10.1016/j.jtumed.2020.03.009. eCollection 2020 Jun. J Taibah Univ Med Sci. 2020. PMID: 32647512 Free PMC article.
-
Inappropriate prescription of allopurinol in a teaching hospital.J Med Assoc Thai. 2007 May;90(5):889-94. J Med Assoc Thai. 2007. PMID: 17596042
-
The Pattern of Allopurinol Prescription Among Chronic Kidney Disease Patients in a Tertiary Care Centre: A Single-Centre Experience.Int J Gen Med. 2021 Mar 30;14:1141-1146. doi: 10.2147/IJGM.S299723. eCollection 2021. Int J Gen Med. 2021. PMID: 33833553 Free PMC article.
-
Urate-lowering therapy for gout: focus on febuxostat.Pharmacotherapy. 2010 Jun;30(6):594-608. doi: 10.1592/phco.30.6.594. Pharmacotherapy. 2010. PMID: 20500048 Review.
-
Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.Clin Ther. 2009 Nov;31(11):2503-18. doi: 10.1016/j.clinthera.2009.11.033. Clin Ther. 2009. PMID: 20109996 Review.
Cited by
-
Allopurinol prescription patterns among patients in a Saudi tertiary care centre.J Taibah Univ Med Sci. 2020 Apr 27;15(3):185-189. doi: 10.1016/j.jtumed.2020.03.009. eCollection 2020 Jun. J Taibah Univ Med Sci. 2020. PMID: 32647512 Free PMC article.
-
Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease.Med Sci Monit. 2024 Jun 12;30:e944314. doi: 10.12659/MSM.944314. Med Sci Monit. 2024. PMID: 38865287 Free PMC article.
References
-
- Schlesinger N, Dalbeth N, Perez-Ruiz F. Gout—what are the treatment options? Expert Opin Pharmacother. 2009;10:1319–28. - PubMed
-
- Hamburger M, Baraf HS, Adamson TC, 3rd, Basile J, Bass L, Cole B, et al. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia. Postgrad Med. 2011;123(6 Suppl 1):3–36. - PubMed
-
- Mackiewicz T. Prevention of tumor lysis syndrome in an outpatient setting. Clin J Oncol Nurs. 2012;16:189–93. - PubMed
LinkOut - more resources
Full Text Sources